Amundi Asset Management US’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-240
| Closed | -$14K | – | 1522 |
|
|
2020
Q3 | $14K | Sell |
240
-2,726
| -92% | -$159K | ﹤0.01% | 1487 |
|
|
2020
Q2 | $207K | Buy |
+2,966
| New | +$207K | ﹤0.01% | 1361 |
|
|
2020
Q1 | – | Sell |
-5,290
| Closed | -$344K | – | 1616 |
|
|
2019
Q4 | $344K | Sell |
5,290
-3,036
| -36% | -$197K | ﹤0.01% | 1362 |
|
|
2019
Q3 | $517K | Sell |
8,326
-1,279
| -13% | -$79.4K | ﹤0.01% | 1304 |
|
|
2019
Q2 | $684K | Hold |
9,605
| – | – | ﹤0.01% | 1295 |
|
|
2019
Q1 | $753K | Hold |
9,605
| – | – | ﹤0.01% | 1237 |
|
|
2018
Q4 | $813 | Buy |
9,605
+4,315
| +82% | +$365 | ﹤0.01% | 1184 |
|
|
2018
Q3 | $906K | Buy |
+5,290
| New | +$906K | ﹤0.01% | 1242 |
|